Using the 2 Stage Free Cash Flow to Equity, OKYO Pharma fair value estimate is US$4.57. OKYO Pharma's US$2.40 share price signals that it might be 47% undervalued. O ...
AngioDynamics, Inc. , a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback